Clinical trial

Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program

NCT02933346

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-09-01

PhaseN/A

Study timeline

Study start (actual)2016-09-01Date precision: month

Registry last updated2023-05-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Nivolumabunresolved

Long-term Adverse Effectsunresolved

Interventions

Sponsors & collaborators

Intergroupe Francophone de Cancerologie Thoraciquelead sponsor

Bristol-Myers Squibbcollaborator

Mapped research locations

ParisFrance5 MarseilleFrance2 CaenFrance2 Clermont-FerrandFrance2 VillejuifFrance2 Saint-HerblainFrance2 LimogesFrance2 ToulouseFrance1 LyonFrance1 StrasbourgFrance1 LilleFrance1 NiceFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02933346 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.